Fig. 1

Waterfall plot of the PSA changes treated by cabazitaxel. The > 50% PSA decrease rate was 19% (22/118) in total. The PSA decrease rates in > 20 mg/m² (red) and ≤ 20 mg/m² (blue) were 29% (11/37) and 14% (11/81), respectively (P = 0.073)